HomeComparePSTTF vs VICI

PSTTF vs VICI: Dividend Comparison 2026

PSTTF yields 1379.31% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSTTF wins by $327926177.97M in total portfolio value
10 years
PSTTF
PSTTF
● Live price
1379.31%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$327926178.94M
Annual income
$286,995,341,463,684.70
Full PSTTF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — PSTTF vs VICI

📍 PSTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPSTTFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PSTTF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PSTTF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSTTF
Annual income on $10K today (after 15% tax)
$117,241.38/yr
After 10yr DRIP, annual income (after tax)
$243,946,040,244,131.97/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, PSTTF beats the other by $243,946,039,727,862.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSTTF + VICI for your $10,000?

PSTTF: 50%VICI: 50%
100% VICI50/50100% PSTTF
Portfolio after 10yr
$163963089.95M
Annual income
$143,497,671,035,530.40/yr
Blended yield
87.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

PSTTF
No analyst data
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSTTF buys
0
VICI buys
0
No recent congressional trades found for PSTTF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPSTTFVICI
Forward yield1379.31%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$327926178.94M$966.2K
Annual income after 10y$286,995,341,463,684.70$607,376.13
Total dividends collected$324920394.51M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PSTTF vs VICI ($10,000, DRIP)

YearPSTTF PortfolioPSTTF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$148,631$137,931.03$11,361$941.49+$137.3KPSTTF
2$2,075,001$1,915,965.64$13,320$1,481.32+$2.06MPSTTF
3$27,218,680$24,998,428.97$16,284$2,405.01+$27.20MPSTTF
4$335,586,754$306,462,766.83$21,040$4,071.78+$335.57MPSTTF
5$3,890,354,077$3,531,276,249.42$29,209$7,285.49+$3890.32MPSTTF
6$42,421,557,343$38,258,878,480.81$44,443$14,006.51+$42421.51MPSTTF
7$435,284,512,667$389,893,446,310.20$75,822$29,512.55+$435284.44MPSTTF
8$4,204,696,744,549$3,738,942,315,995.26$148,733$69,726.75+$4204696.60MPSTTF
9$38,253,119,134,080$33,754,093,617,412.28$344,394$189,413.75+$38253118.79MPSTTF
10$327,926,178,937,150$286,995,341,463,684.70$966,234$607,376.13+$327926177.97MPSTTF

PSTTF vs VICI: Complete Analysis 2026

PSTTFStock

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Full PSTTF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this PSTTF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSTTF vs SCHDPSTTF vs JEPIPSTTF vs OPSTTF vs KOPSTTF vs MAINPSTTF vs NNNPSTTF vs EPRTPSTTF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.